{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:58:48Z","timestamp":1790827128324,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Maryam Rezaei Nasab","award":["K\/142"],"award-info":[{"award-number":["K\/142"]}]},{"DOI":"10.13039\/501100004847","name":"Zahedan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.meegid.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T09:37:05Z","timestamp":1549791425000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Protection induced by Leishmania Major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis"],"prefix":"10.1016","volume":"70","author":[{"given":"Ahmad","family":"Mehravaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Rezaei","family":"Nasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Mirahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Alijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin Reza","family":"Nikpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Akhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2019.01.005_bb0005","series-title":"Science-AAAS-Weekly Paper Edition-including Guide to Scientific Information","first-page":"235","article-title":"The adjuvant effect of interleukin-12 in a vaccine against Leishmania major","volume":"vol. 263","author":"Afonso","year":"1994"},{"key":"10.1016\/j.meegid.2019.01.005_bb0010","first-page":"23","article-title":"The p reparation and evaluation of reference leishmanin from leishmania major for use in man for diagnostic and experimental purposes","volume":"7","author":"Alimohammadian","year":"1993","journal-title":"Med. J. Islam. Repub. Iran"},{"key":"10.1016\/j.meegid.2019.01.005_bb0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1749-6632.1995.tb44447.x","article-title":"Liposomal vaccines: clinical status and immunological presentation for humoral and cellular immunity","volume":"754","author":"Alving","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.meegid.2019.01.005_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.exppara.2006.07.002","article-title":"Leishmania major: immune response in BALB\/c mice immunized with stress-inducible protein 1 encapsulated in liposomes","volume":"115","author":"Badiee","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0025","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/CVI.00413-07","article-title":"Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB\/c mice","volume":"15","author":"Badiee","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.colsurfb.2009.06.025","article-title":"Enhancement of immune response and protection in BALB\/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): the role of bilayer composition","volume":"74","author":"Badiee","year":"2009","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.meegid.2019.01.005_bb0035","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.vaccine.2012.11.068","article-title":"Micro\/nanoparticle adjuvants for antileishmanial vaccines: present and future trends","volume":"31","author":"Badiee","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2019.01.005_bb0040","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ab.2010.11.015","article-title":"Bicinchoninic acid (BCA) assay in low volume","volume":"410","author":"Bainor","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.meegid.2019.01.005_bb0045","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.vaccine.2010.11.061","article-title":"Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination","volume":"29","author":"Bal","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2019.01.005_bb0050","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1016\/j.vaccine.2007.05.042","article-title":"Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response","volume":"25","author":"Bhowmick","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2019.01.005_bb2000","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.4049\/jimmunol.166.5.3416","article-title":"General suppression of macrophage gene expression during Leishmania donovani infection","volume":"1","author":"Buates","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0055","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis","volume":"70","author":"Coler","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.meegid.2019.01.005_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1440-1711.2005.01315.x","article-title":"Lipid based particulate formulations for the delivery of antigen","volume":"83","author":"Copland","year":"2005","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional T H 1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.meegid.2019.01.005_bb0070","first-page":"229","article-title":"Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics","volume":"61","author":"Davis","year":"1987","journal-title":"Immunology"},{"key":"10.1016\/j.meegid.2019.01.005_bb0075","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/CJI.0b013e31802cf3e3","article-title":"\u201cPathogen-mimicking\u201d nanoparticles for vaccine delivery to dendritic cells","volume":"30","author":"Elamanchili","year":"2007","journal-title":"J. Immunother."},{"key":"10.1016\/j.meegid.2019.01.005_bb0080","article-title":"Development of vaccines against visceral leishmaniasis","volume":"2012","author":"Evans","year":"2011","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.meegid.2019.01.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1590\/S0100-879X1999000200006","article-title":"Liposomes: from biophysics to the design of peptide vaccines","volume":"32","author":"Frezard","year":"1999","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.meegid.2019.01.005_bb0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.vetpar.2015.01.003","article-title":"Canine Leishmania vaccines: still a long way to go","volume":"208","author":"Gradoni","year":"2015","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0095","series-title":"The Present and Future of Vaccination for Cutaneous Leishmaniasis","first-page":"259","article-title":"The present and future of vaccination for cutaneous leishmaniasis","author":"Greenblatt","year":"1980"},{"key":"10.1016\/j.meegid.2019.01.005_bb0100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13071-016-1381-0","article-title":"The TLR2\/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models","volume":"9","author":"Halliday","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.meegid.2019.01.005_bb0105","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.pt.2014.05.006","article-title":"The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis","volume":"30","author":"Hartley","year":"2014","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0110","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1007\/s00253-016-7422-y","article-title":"Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica","volume":"100","author":"Heidari-Kharaji","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.meegid.2019.01.005_bb2005","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"22","author":"Hemmi","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0115","first-page":"71","article-title":"DDA\/TDB liposomes containing soluble Leishmania major antigens induced a mixed Th1\/Th2 immune response in BALB\/c mice","volume":"4","author":"Hojatizade","year":"2017","journal-title":"Nanomed. J."},{"key":"10.1016\/j.meegid.2019.01.005_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2009.01.004","article-title":"Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes","volume":"136","author":"Homhuan","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.meegid.2019.01.005_bb0125","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V96.10.3505","article-title":"Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo","volume":"96","author":"Ignatius","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2019.01.005_bb0130","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune response","volume":"5","author":"Iwasake","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0135","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0140","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1016\/j.vaccine.2007.05.009","article-title":"The role of CpG ODN in enhancement of immune response and protection in BALB\/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome","volume":"25","author":"Jaafari","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2019.01.005_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2012.05.010","article-title":"Targeting tumor antigens to dendritic cells using particulate carriers","volume":"161","author":"Joshi","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.meegid.2019.01.005_bb0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ni0602-499","article-title":"Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848","volume":"3","author":"Jurk","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2012.09.013","article-title":"Block copolymer micelles for drug delivery: design, characterization and biological significance","volume":"64","author":"Kataoka","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.meegid.2019.01.005_bb0160","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"Khamesipour","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.meegid.2019.01.005_bb0165","first-page":"2526","article-title":"Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge","volume":"63","author":"Krishnan","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.meegid.2019.01.005_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178846","article-title":"Insights on the mechanism of action of immunostimulants in relation to their pharmacological potency. The effects of imidazoquinolines on TLR8","volume":"12","author":"Kubli-Garfias","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2019.01.005_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/srep27206","article-title":"A lipid based antigen delivery system efficiently facilitates MHC Class-I antigen presentation in dendritic cells to stimulate CD8+ T cells","volume":"6","author":"Maji","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.meegid.2019.01.005_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001429","article-title":"Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection","volume":"5","author":"Mazumder","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.meegid.2019.01.005_bb0185","first-page":"274","article-title":"Cationic immune stimulating complexes containing soluble Leishmania antigens: preparation, characterization and in vivo immune response evaluation","volume":"12","author":"Mehravaran","year":"2015","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0190","first-page":"249","article-title":"The role of surface charge of ISCOMATRIX nanoparticles on the type of immune response generated against Leishmaniasis in BALB\/c mice. Nanomedicine","volume":"2","author":"Mehravaran","year":"2015","journal-title":"Journal"},{"key":"10.1016\/j.meegid.2019.01.005_bb0195","first-page":"178","article-title":"The role of ISCOMATRIX bilayer composition to induce a cell mediated immunity and protection against leishmaniasis in BALB\/c mice","volume":"19","author":"Mehravaran","year":"2016","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.meegid.2019.01.005_bb0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nmat2960","article-title":"Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses","volume":"10","author":"Moon","year":"2011","journal-title":"Nat. Mater."},{"key":"10.1016\/j.meegid.2019.01.005_bb0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7555\/JBR.27.20120064","article-title":"Development of Leishmania vaccines: predicting the future from past and present experience","volume":"27","author":"Mutiso","year":"2013","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.meegid.2019.01.005_bb0210","series-title":"Leishmania: After the Genome","author":"Myler","year":"2008"},{"key":"10.1016\/j.meegid.2019.01.005_bb0215","series-title":"Bulletin de la Soci\u00e9t\u00e9 de Pathologie Exotique et de ses Filiales","first-page":"377","article-title":"Effectiveness of leishmanization in the control of cutaneous leishmaniasis","volume":"vol. 76","author":"Nadim","year":"1983"},{"key":"10.1016\/j.meegid.2019.01.005_bb0220","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2019.01.005_bb0225","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jps.20098","article-title":"Current methods for attaching targeting ligands to liposomes and nanoparticles","volume":"93","author":"Nobs","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.meegid.2019.01.005_bb0230","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11095-010-0301-9","article-title":"Incorporation of the TLR4 agonist monophosphoryl lipid A into the bilayer of DDA\/TDB liposomes: physico-chemical characterization and induction of CD8+ T-cell responses in vivo","volume":"28","author":"Nordly","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.meegid.2019.01.005_bb0235","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2249.2003.02096.x","article-title":"Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma","volume":"131","author":"Nylen","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0240","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/14760584.2.2.269","article-title":"Microparticles as vaccine adjuvants and delivery systems","volume":"2","author":"O'Hagan","year":"2003","journal-title":"Exp. Rev. Vaccines"},{"key":"10.1016\/j.meegid.2019.01.005_bb0245","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1208\/s12249-016-0553-8","article-title":"Surface-modified liposomal formulation of amphotericin B: in vitro evaluation of potential against visceral leishmaniasis","volume":"18","author":"Patere","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.meegid.2019.01.005_bb0250","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.imbio.2005.06.002","article-title":"Human dendritic cells and macrophages exhibit different intracellular processing pathways for soluble and liposome-encapsulated antigens","volume":"210","author":"Peachman","year":"2005","journal-title":"Immunobiology"},{"key":"10.1016\/j.meegid.2019.01.005_bb0255","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.addr.2015.11.005","article-title":"Designing liposomal adjuvants for the next generation of vaccines","volume":"99","author":"Perrie","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.meegid.2019.01.005_bb0260","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fimmu.2012.00144","article-title":"Adjuvants for Leishmania vaccines: from models to clinical application","volume":"3","author":"Raman","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0265","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection","volume":"195","author":"Rhee","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2019.01.005_bb0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.139.1.221","article-title":"Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes","volume":"139","author":"Scott","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0275","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"Smith","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0280","article-title":"Searching genes encoding Leishmania antigens for diagnosis and protection","volume":"2009","author":"Soto","year":"2009","journal-title":"Sch. Res. Exch."},{"key":"10.1016\/j.meegid.2019.01.005_bb0285","first-page":"573","article-title":"Immunization against cutaneous leishmaniasis by alginate microspheres loaded with Autoclaved Leishmania Major (ALM) and Quillaja Saponins","volume":"15","author":"Tafaghodi","year":"2016","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.meegid.2019.01.005_bb0290","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0295","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.4049\/jimmunol.126.4.1614","article-title":"Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis","volume":"126","author":"Taswell","year":"1981","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0300","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0305","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.meegid.2019.01.005_bb0310","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.4049\/jimmunol.167.12.6967","article-title":"Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease","volume":"167","author":"Uzonna","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0315","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ni1092","article-title":"NOD2 is a negative regulator of Toll-like receptor 2\u2013mediated T helper type 1 responses","volume":"5","author":"Watanabe","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.meegid.2019.01.005_bb0320","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.vaccine.2012.01.070","article-title":"Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens","volume":"30","author":"Watson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2019.01.005_bb0325","series-title":"World Health Statistics 2016: Monitoring Health for the SDGs Sustainable Development Goals","author":"WHO","year":"2016"},{"key":"10.1016\/j.meegid.2019.01.005_bb0330","series-title":"Targeting the Tolls","author":"Wickelgren","year":"2006"},{"key":"10.1016\/j.meegid.2019.01.005_bb0335","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/IAI.01527-07","article-title":"Immunization with a Toll-like receptor 7 and\/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB\/c mice","volume":"76","author":"Zhang","year":"2008","journal-title":"Infect. Immun."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134818308141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134818308141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T10:30:03Z","timestamp":1694601003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134818308141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":69,"alternative-id":["S1567134818308141"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2019.01.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735058604.793580951","asserted-by":"object"}]},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection induced by Leishmania Major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}